Real-time enrollment status for this autism spectrum disorder clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 10:32 AM UTC
| NCT Number | NCT05081245 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Autism Spectrum Disorder |
| Phase | Clinical Trial |
| Target Enrollment | 150 participants |
| Active Locations | 33 sites in the US |
| Sponsor | MapLight Therapeutics |
| Last Updated on CT.gov | December 22, 2025 (Dec 22, 2025) |
As of March 2, 2026: Clinical trial NCT05081245 is currently active_not_recruiting participants. This clinical trial study for autism spectrum disorder is not currently accepting new participants at 33 locations across the United States. The study is sponsored by MapLight Therapeutics. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05081245 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 33 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05081245 was last updated Dec 22, 2025 (December 22, 2025). HelloStudys verifies this status automatically.